Clinical Trials
86 trialsTRIDENT-1
Turning Point Therapeutics, Inc.
SUNRAY-01
Eli Lilly and Company
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Revolution Medicines, Inc.
Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors
Revolution Medicines, Inc.
LADOGA
AstraZeneca
NADIM-ADJUVANT
Fundación GECP
MERLIN
Fundación GECP
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Stanford University
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Revolution Medicines, Inc.
LIBRETTO-001
Eli Lilly and Company
A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
MediLink Therapeutics (Suzhou) Co., Ltd.
Prophylactic Inhaled Steroids to Reduce Radiation Pneumonitis Frequency and Severity in Lung Cancer Patients
Instituto Nacional de Cancerologia de Mexico
Post-operative Medium Chain Triglyceride Diet May Reduce Hospital Stay Following Lung Resection
Chinese University of Hong Kong
REVIVE
AstraZeneca
NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
NeoImmuneTech
AcceleRET-Lung
Hoffmann-La Roche
LOTOS
AstraZeneca
Erector Spinae Block for Thoracic Surgery
George Washington University
VALOR
VA Office of Research and Development
LIBRETTO-121
Eli Lilly and Company
ANC-IIT-004
Affiliated Hospital of Nantong University
EmoVie_K2
University Hospital, Lille
Post-line Treatment With Teniposide for c-Myc-driven Extensive-stage Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China
TELESCOPE-H
Rutgers, The State University of New Jersey
FIRSTLUNG
Delfi Diagnostics Inc.
PALACE
Fundación GECP
IMPROVE
Memorial Sloan Kettering Cancer Center
Pharmacokinetic Study of QL2107 Versus Keytruda® for Adjuvant Therapy of Non-Small Cell Lung Cancer (NSCLC)
Qilu Pharmaceutical Co., Ltd.
AFFINITY
Galvanize Therapeutics, Inc.
SPSIPB vs SAPB for Thoracoscopic Surgery
Medipol University
Pain Control After VATS Anatomical Pulmonary Resections
University Hospital Padova
Studying a New Piece of Equipment That Can Help Plan Radiation Therapy of the Spine
Memorial Sloan Kettering Cancer Center
ARROW
Hoffmann-La Roche
Early Intervention Strategies for Lung Cancer
The First Affiliated Hospital of Guangzhou Medical University
Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer Patients
Thomas Jefferson University
The Effects of a Family-Centered Tai Chi Exercise on Lung Function and Mental Health of Patients After Thoracoscopic Surgery
China Medical University Hospital
Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors
Revolution Medicines, Inc.
APOLO
Fundación GECP
Neo-DIANA: Neoadjuvant Treatment for EGFR Mutated Patients
Fundación GECP
(SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC
Blueprint Medicines Corporation
(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations
Blueprint Medicines Corporation
VIGOR
Galvanize Therapeutics, Inc.
ParaSOL
Guy's and St Thomas' NHS Foundation Trust
A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC
Nanfang Hospital, Southern Medical University
ILST
The University of Queensland
CanStem43L
Sumitomo Pharma America, Inc.
Palpator
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
mHealth ALIBIRD: A Digital Health Care Model
Fundación Investigación E Innovación Biomédica Hospital Universitario Infanta Sofia-Henares
Durvalumab (MEDI4736) With or Without SBRT in Clinical Stage I, II and IIIA Non-small Cell Lung Cancer
Weill Medical College of Cornell University
Metformin Pharmacology in Human Cancers: A Proof of Principle Study
Dartmouth-Hitchcock Medical Center